logo
logo

Enlightenvue™ Announces First Closing Of $1 Million Series B Financing To Expand Applications Of Surgivue™ Single-Use Micro-Endoscope Platform

Apr 20, 2022•about 3 years ago

Amount Raised

$1 Million

Round Type

series b

Denver

Description

enlightenVueTM, Inc. announced today the initial closing of a $1 million Series B financing to expand the application of its FDA-cleared, surgiVueTM single-use micro-endoscope platform.

Company Information

Company

Enlighten Vue

Location

Denver, Colorado, United States

About

enlightenVue has developed a novel single-use micro-endoscope platform with the industry’s smallest working diameter (2mm) and multiple working channels that can be used in a single procedure for both diagnostic and therapeutic interventions. The surgiVue™ platform’s dual functionality is based on a patented, expandable tip to provide access for multiple instruments along with superior optics. The system, which has 510(k) clearance, enables use across multiple specialties and healthcare settings to provide significant benefits to patients, clinicians, and the healthcare system, and removing the risk of infection transmission. Learn more at enlightenVue.com.